Idioma:

Should CYP2D6 be genotyped when treating with tamoxifen?

Del Re, Marzia ; Rofi, Eleonora ; Citi, Valentina ; Fidilio, Leonardo ; Danesi, Romano

Pharmacogenomics, 2017-06, Vol.18 (8), p.755-756 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Should CYP2D6 be genotyped when treating with tamoxifen?
Autor: Del Re, Marzia ; Rofi, Eleonora ; Citi, Valentina ; Fidilio, Leonardo ; Danesi, Romano
Assuntos: Antineoplastic Agents, Hormonal - therapeutic use ; Breast cancer ; Breast Neoplasms - drug therapy ; Breast Neoplasms - genetics ; CYP2D6 protein ; Cytochrome P-450 CYP2D6 - genetics ; Cytochrome P450 ; Deoxyribonucleic acid ; DNA ; Editorials ; Female ; Genotype ; Genotype & phenotype ; Genotyping ; Humans ; Pharmacogenomics ; Tamoxifen ; Tamoxifen - therapeutic use
É parte de: Pharmacogenomics, 2017-06, Vol.18 (8), p.755-756
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Letter in regards to: Del Re M, Rofi E, Citi V, Fidilio L, Danesi R. Should CYP2D6 be genotyped when treating with tamoxifen? Pharmacogenomics 17(18), 1967-1969 (2016). In response to: Damkier P. Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients. Pharmacogenomics 18(8), XXX (2017).
Editor: England: Future Medicine Ltd
Idioma: Inglês

Links

Voltar para lista de resultados